[ad_1]
The data of the Department of Health on the incidence of coronavirus in Moscow in the summer of 2021 allow us to conclude that the EpiVacCorona vaccine is ineffective. About it says in the Meduza study, which obtained the relevant data from a source with access to the Moscow incidence monitoring system.
As noted in the material, the publication staff compared the proportion of registered cases in Moscow among those vaccinated with different drugs in groups of different ages, taking into account the total population of the city in different age groups, as well as the proportion of those vaccinated with different drugs in these age groups.
It is emphasized that during the analysis of the results of the use of EpiVacCorona in Moscow, this drug did not show any effectiveness. At the same time, internal data on the incidence of COVID-19, which the Moscow Department of Health has, confirm the protective efficacy of another Russian vaccine, Sputnik V.
The authors of the study devoted scientific research to the analysis of the obtained data. manuscript, as well as posted own calculations on the GitHub portal.
Previously, the negative effectiveness of EpiVacCorona was announced by scientists from St. submitted results of the first comparative study of the effectiveness of all Russian vaccines against the Delta strain. It was held in October 2021, before the advent of the omicron.
Scientists from the Institute for Interdisciplinary Medical Research at the European University at St. Petersburg evaluated how vaccination protects against the symptomatic course of coronavirus infection and lung damage. The efficiency of Sputnik V was 58%, Sputnik Light – 50%, KoviVac – 38%, and EpiVacCorona – minus 40%.
Developers from the Vector Center (EpiVakKorona) and the Institute. Chumakova (KoviVak) pointed out errors in the study and did not recognize the conclusions of their colleagues. The conclusions contain a number of assumptions that require additional research, the creators of the vaccines say. At the Institute. Chumakov, however, stated that this study “is of undoubted interest to them.”
Recall that the EpiVacCorona vaccine has long been located at the center of the scandal (its effectiveness is extremely doubtful, and its developers are accused of falsifying data), but it has not yet been withdrawn from circulation.
[ad_2]
Source link
